Magellan Diagnostics (Meridian Bioscience, Inc., NASDAQ: VIVO) Launches National Education Initiative on Risks of Lead Exposure for Pregnant Women
Kickoff panel highlights common risks and what obstetricians can do to help protect their patients. CINCINNATI, May 09, 2017 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ:VIVO) announced today that Magellan Diagnostics Inc., a business unit of Meridian, has embarked on a major new initiative to increase awareness among obstetricians and pregnant women about the risks […]